España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Stereotaxis
STXS
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.34
-0.01
-0.43%
At close: -
$2.34
0.00
0.00%
After Hours: 1:01 PM EDT
Get Report
Comment
Stereotaxis (STXS) Forecast
News
Earnings
Stereotaxis (STXS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Stereotaxis (AMEX:STXS) Stock
Stereotaxis Stock (AMEX: STXS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 09, 2024
Stereotaxis and MicroPort EP Secure NMPA Appr...
Benzinga Newsdesk
Monday, November 25, 2024
Stereotaxis Genesis Robotic System Secures Re...
Benzinga Newsdesk
Wednesday, November 20, 2024
Stereotaxis Announces That Physicians At The ...
Benzinga Newsdesk
Monday, November 11, 2024
Stereotaxis Q3 2024 GAAP EPS $(0.08) Misses $...
Benzinga Newsdesk
Earnings Scheduled For November 11, 2024
Benzinga Insights
Friday, November 08, 2024
Stereotaxis Earnings Preview
Benzinga Insights
Wednesday, November 06, 2024
Stereotaxis Announces University Of Kansas Me...
Benzinga Newsdesk
Monday, August 12, 2024
Stereotaxis Q2 2024 GAAP EPS $(0.07) Misses $...
Benzinga Newsdesk
Stereotaxis shares are trading higher after t...
Benzinga Newsdesk
Stereotaxis Achieves CE Mark In Europe And Su...
Benzinga Newsdesk
Thursday, August 08, 2024
AxoGen Q2 Earnings and Revenues Beat Estimates
Zacks
Tuesday, June 18, 2024
Hyliion Holdings And 3 Other Penny Stocks Insiders Are Buying
Avi Kapoor
Wednesday, May 29, 2024
Stereotaxis Announces Penn Presbyterian Medic...
Benzinga Newsdesk
Friday, May 24, 2024
Stereotaxis Receives CE Mark Recertification ...
Benzinga Newsdesk
Wednesday, May 22, 2024
Stereotaxis Announces First Heart Rhythm Pati...
Benzinga Newsdesk
Wednesday, May 15, 2024
Stereotaxis Invited By Africa Heart Rhythm As...
Benzinga Newsdesk
Monday, May 13, 2024
Stereotaxis Q1 2024 GAAP EPS $(0.06), Inline,...
Benzinga Newsdesk
Stereotaxis Signs Definitive Agreement To Acq...
Benzinga Newsdesk
Tuesday, March 05, 2024
Lake Street Maintains Buy on Stereotaxis, Rai...
Benzinga Newsdesk
Roth MKM Reiterates Buy on Stereotaxis, Maint...
Benzinga Newsdesk
Monday, March 04, 2024
Stereotaxis Anticipates Double Digit Revenue ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Recap: Stereotaxis Q4 Earnings
Benzinga Insights
Stereotaxis Says Regulatory Submissions Were ...
Benzinga Newsdesk
Stereotaxis Q4 2023 GAAP EPS $(0.070), Inline...
Benzinga Newsdesk
Earnings Scheduled For March 4, 2024
Benzinga Insights
Friday, March 01, 2024
Earnings Preview For Stereotaxis
Benzinga Insights
Friday, January 12, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, January 10, 2024
Roth MKM Initiates Coverage On Stereotaxis wi...
Benzinga Newsdesk
Monday, January 08, 2024
Stereotaxis Announces First Patients Treated ...
Benzinga Newsdesk
Wednesday, December 06, 2023
Insiders Buying Eyenovia And 3 Other Stocks Under $2
Lisa Levin
Tuesday, November 28, 2023
Stereotaxis And Baptist Health Lexington Anno...
Benzinga Newsdesk
Thursday, November 09, 2023
Recap: Stereotaxis Q3 Earnings
Benzinga Insights
Stereotaxis Q3 EPS $(0.07) Misses $(0.06) Est...
Benzinga Newsdesk
Tuesday, October 31, 2023
Abbott And Stereotaxis Technologies Used In F...
Benzinga Newsdesk
Monday, September 18, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, September 06, 2023
Stereotaxis Announces Heart Centre Rigshospitalet Enhances Leadership In Patient Care With Adoption of Latest Robotic Technology
Happy Mohamed
Tuesday, August 29, 2023
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
Lisa Levin
Thursday, August 10, 2023
Stereotaxis Clocks 28% Revenue Growth In Q2 On Continued Demand For Robotic Technology
Nabaparna Bhattacharya
Stereotaxis Q2 EPS $(0.07), Inline, Sales $7....
Benzinga Newsdesk
Tuesday, July 18, 2023
Stereotaxis And Abbott Combine Technologies In First Integrated Procedures To Treat Arrhythmia Patients
Happy Mohamed
Thursday, July 06, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, June 16, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Stereotaxis shares are trading lower. The com...
Benzinga Newsdesk
US Stocks Mixed; Dow Gains 50 Points
Lisa Levin
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, June 15, 2023
Stereotaxis To Initiate First-In-Human Trial ...
Benzinga Newsdesk
Tuesday, May 23, 2023
Stereotaxis Announces The First Treatment Of ...
Benzinga Newsdesk
Friday, May 19, 2023
Crude Oil Down 1%; Foot Locker Earnings Miss Expectations
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch